In order to assess further the absence of tumour DNA in the cervical smear samples we used MethyLight, a real time PCR-based method, to amplify methylated ZNF154, a pan-cancer marker primarily discovered in ovarian cancer25,26. Here, ZNF154 is linked to neoplasm.